Why this ASX cannabis share price is in limbo today

Trading in shares of Althea Group Holdings Ltd (ASX: AGH) has been halted amid reports that a major shareholder and supplier is heading for the door.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Althea Group Holdings Ltd (ASX:AGH) shares are in a trading halt pending an announcement, with rumours swirling that major shareholder and supplier Aphria is looking to sell their stake in the Australia marijuana supplier. Althea shares have been flying high since their IPO, sitting at around 52 cents since listing at 20 cents.

Aphria supplies both expertise and the products that Althea distributes in Australia, named 'Capilano', 'Champlain Indica', 'Jasper', and 'Rideau'. The plan is for Althea to start producing its own versions of these products in Australia using clone starting materials. First, though, Althea will need to get its production facility up and running. The $3 million of funds raised in Althea's IPO were earmarked for the construction of the facility in Victoria.

The Australian Financial Review (AFR) has reported that the trading halt was prompted by a material supply agreement, which raises questions about the ongoing supply of products by Aphria to Althea. Further, according to the AFR, stockbroker PAC Partners is organising a group of investors to buy 37 million shares, or a 16% stake, in Althea.

According to the report, the shares could be sold at 40 cents each, a steep discount to current market prices. Aphria, a Canadian marijuana company, has been a key strategic stakeholder in Althea. As at the date of Althea's annual report, Aphria held 50,750,000 shares, nearly 25% of shares on issue, but the AFR article reports that it has been selling on-market in recent days.

Aphria initially invested in Althea at the start of 2018, agreeing to the supply agreement in exchange for a 25% stake in the Australian cannabis company. The deal expanded Aphria's global footprint, with Aphria's CEO stating at the time that Australia's fledgling medical cannabis market was a key pillar of Aphria's international expansion strategy.

Why Aphria may have had a change of heart is unclear, but it has been reported that some marijuana producers are reducing exposure to Australia in an effort to clean up their balance sheets. Althea shares are due to resume trading tomorrow, or when an announcement is released to market.

Cannabis stocks have been in decline of late as the the vaping crisis in the US takes its toll. Auscann Group Holdings Ltd (ASX: AC8) has lost 65% of its value to sit around 27 cents from 77 cents in January. Cann Group Ltd (ASX: CAN) is down to $1.04 from highs of $2.57 in April. Likewise Creso Pharma Ltd (ASX: CPH) is languishing around 26 cents after reaching 55 cents in June.

Foolish takeaway

Althea has been one of the outperformers pot stock sector, but for now it's a wait and see on whether that will continue.

Motley Fool contributor Kate O'Brien has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 managed a gain today, but only just.

Read more »

a female steel worker wearing a high visibility vest with her protective helmet tucked under her arm smiles as she carries a clipboard in a large warehouse of steel products.
Earnings Results

Looking at BlueScope shares? Here's your half-year results preview

What is the market expecting for the first half?

Read more »

Teen standing in a city street smiling and throwing sparkling gold glitter into the air.
52-Week Highs

11 ASX 200 stocks streaking to multi-year highs today

The benchmark ASX 200 is in the green and these 11 stocks are setting new price records.

Read more »

Miner looking at a tablet.
Resources Shares

Why is the South32 share price taking such a shellacking today?

A whale move might be behind today's big slump.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Share Gainers

Why Evolution Mining, Macquarie, Ramsay, and SGH shares are pushing higher today

These shares are having a good session on Tuesday. Let's see what is getting investors excited.

Read more »

A young boy wearing a hat, sunnies and striped singlet looks fierce and flexes his arm in victory.
Broker Notes

Experts reveal 4 ASX small-cap shares to buy now

ASX small-cap shares are slightly outperforming the broader market in 2025.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Breville, Domino's, Liontown, and WiseTech shares are falling today

These shares are out of form on Tuesday. What's going on?

Read more »

Person handing out $50 notes, symbolising ex-dividend date.
Share Market News

3 fantastic ASX ETFs to buy with $5,000 this week

These funds could be great options for investors with money to put into the market this week.

Read more »